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Abstract: Characterization of cognitive and behavioral complaints is explored in Post-traumatic 
stress disorder (PTSD) and mild traumatic brain injury (MTBI) samples according to the 
severity of PTSD, depression and general anxiety conditions. Self-reported questionnaires 
on cognitive and behavioral changes are administered to PTSD, MTBI, MTBI/PTSD and 
control groups. Confounding variables are controlled. All groups report more complaints 
since the traumatic event. PTSD and MTBI/PTSD groups report more anxiety symptoms, 
depression and complaints compared to the MTBI group. Relatives of the PTSD group 
confirm most of the behavioral changes reported. Results suggest the utility of self-reported 
questionnaires to personalize cognitive and behavioral interventions in PTSD and MTBI to 
cope with the impacts of the traumatic event. 
Keywords: cognitive and behavioral complaints; PTSD; MTBI; comorbidity;  
depression; anxiety 
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1. Introduction 
Clinical psychologists who work with individuals with post-traumatic stress disorder (PTSD) are 
often faced with complaints of persistent cognitive problems, including difficulties with memory and 
concentration, which can cause a decrease in the effectiveness of the therapeutic interventions. It 
frequently happens that such cognitive or behavioral changes may be ignored or minimized during the 
initial hospitalization when severe psychological reactions or obvious physical injuries are present [1]. 
Mild traumatic brain injuries (MTBI) represent approximately 85% of all traumatic brain injuries in 
North America [2]. The cluster of acute symptoms that develop following an MTBI is referred to as 
post-concussion syndrome (PCS). The symptoms (e.g., headaches, dizziness, irritability, memory and 
concentration problems) become chronic in 5% to 15% of individuals [3] and tend to partially overlap 
or be confounded with PTSD symptoms [4]. PTSD following a traumatic event further complicates the 
evaluation, the diagnosis and the treatment of the physical and neurological injuries. 
The PTSD clinical population may also present with MTBI subsequent to an accident, physical assault 
or military operation. For example, MTBI is the second most common problem among injured survivors 
of the military operations in Iraq and Afghanistan, second only to orthopedic injuries, according to 
Tanelian and Jaycox [5]. Not surprisingly, the literature in this area refers to MTBI as the “signature 
injury” in these two military conflicts. MTBI most commonly occurs during attacks by improvised explosive 
devices (IED). Survivors may present concomitant PTSD subsequent to the same event, thereby further 
complicating the evaluation, diagnosis and treatment of the physical and neurological injuries. 
Neuropsychologists may wish to refer such patients to psychologists specialized in PTSD to determine 
whether or not psychological treatment is recommended. A client may present persistent PCS that may 
have been hidden or exacerbated by the psychological condition. 
In the context of medical or psychological healthcare services for individuals with PTSD and/or 
MTBI, psychologists and neuropsychologists rarely work in an interdisciplinary environment that would 
allow the two problems to be simultaneously addressed through, for example, a combined treatment 
plan. Given the lack of opportunity for interdisciplinary treatment, the use of questionnaires measuring 
the nature and the intensity of cognitive and behavioral changes post-event should be considered. Such 
questionnaires are fast, cost-effective and allow clinicians to improve the planning and the orientation 
of their evaluations and their treatment. 
The few studies that address cognitive problems in MTBI and PTSD primarily focus on military 
veterans with PTSD [6] or on civilians with MTBI [7,8]. Two studies [9,10] explored the nature of 
complaints in individuals with PTSD and self-reported MTBI. Hoge and McGurk [10] noted that the 
characteristics of the physical and cognitive complaints of MTBI (e.g., brief loss or alteration in 
consciousness) reported by veterans from Iraq are also characteristic of the PTSD and comorbid 
depression symptoms. The authors inferred a mediating role of PTSD and depression in the expression 
of physical and cognitive symptoms in veterans with presumed double diagnoses. Vanderploeg and 
Belanger [9] studied a mixed group comprising soldiers and civilians with chronic PTSD and subsequent 
MTBI sustained several months or years later. Their results suggested that when MTBI occurs in the 
context of pre-existing PTSD, the effectiveness of psychological treatment for the traumatic symptoms 
is compromised. According to Vanderploeg and Belanger [9], PTSD contributes more significantly to 
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subjective physical, cognitive and emotional symptoms than MTBI and that neither condition moderates 
the symptomatology of the other; rather, their effect is cumulative. 
Certain methodological problems in previous studies limit the generalization of the findings. For 
example, the conclusions of two previous studies [9,10] are respectively based on statistical analyses 
conducted with data from a few general questions concerning attention and memory and from clinical 
populations whose diagnoses were established from subjective, retrospective reports. Furthermore, the 
MTBI and PTSD diagnoses were not based on formal medical or psychological evaluations, and the 
absence of a control group precludes information about baseline symptoms in the general population. 
Finally, some study designs did not adequately control for the presence of pre-existing or concurrent 
medical, neurological and developmental conditions, making it difficult to know if participants’ reports 
of their complaints were unaffected by these conditions. 
The objective of the present study was to describe and document the subjective cognitive and 
behavioral symptoms of PTSD and MTBI, while considering some of the methodological problems of 
past studies. In light of the exploratory nature of the study and the limited existing literature in the area, 
three research questions were developed: (1) Given the overlap in clinical symptomatology between 
PTSD and MTBI, are the symptoms reported by individuals in these two groups similar in nature and 
intensity? (2) Does the presence of comorbid MTBI and PTSD intensify the expression of symptoms in 
a “cumulative” effect, as suggested by Vanderploeg and colleagues (2009)? (3) Are the complaints 
reported by the three clinical groups independently validated by relatives, as in Biddle and  
colleagues (2002)? 
2. Methods 
2.1. Participants 
In total, 75 subjects were distributed into four groups in the study. The subsample sizes are specified 
in each of the following subsections. Reports of cognitive and behavioral symptoms were gathered from 
three groups of participants with psychological and/or neurological trauma: individuals with PTSD, 
individuals with MTBI and individuals with a double diagnosis of PTSD and MTBI. 
2.1.1. PTSD Group 
Twenty five civilian participants with a formal diagnosis of PTSD were included in the study. The 
participants were recruited through advertisements in the community or were referred by medical or 
mental health professionals at the Centre d’Étude sur le Trauma (Trauma Studies Center) at the Institut 
Universitaire en Santé Mentale de Montréal. 
2.1.2. MTBI Group 
Nineteen civilian participants with a formal diagnosis of MTBI (based on medical records of the 
accident or assault) were included in the study. Criteria for MTBI were based on the international 
definition of mild traumatic brain injury (see Carroll and Cassidy [3]). The criteria were as follows: 
period of altered consciousness for less than 30 min, Glasgow Coma Scale score between 13 and 15 and  
post-traumatic amnesia (PTA) for less than 24 h. Formal MTBI diagnoses were established by a doctor 
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(neurologist or emergency physician) following admission to the emergency department or later, during  
the medical evaluation process of neurological sequelae. Participants were recruited in a tertiary 
rehabilitation centre for traumatic brain injury (Centre de Réadaptation Lucie-Bruneau (Lucie Bruneau 
Rehabilitation Centre)) in Montreal. 
2.1.3. MTBI/PTSD Group 
Following the evaluation of the medical history and the psychiatric condition, six participants with 
MTBI were also diagnosed with PTSD (MTBI/PTSD) and were recruited from the Lucie Bruneau 
Rehabilitation Centre following evaluation using the SCID-I (the Structured Clinical Interview for  
DSM-IV for Axis I). 
2.1.4. Control Group 
The twenty-five participants in this group were recruited through advertisements in the newspapers 
or on the Internet. Each participant in this group was between 18 and 60 years old and was recruited to 
be as close in age and gender to both PTSD and MTBI groups as possible. 
2.2. Language and Litigation 
The PTSD and MTBI groups matched in ethnicity and language (mostly Caucasian, with French as 
their first language). The few foreign participants in each group were screened over the telephone to 
ensure that their oral and written French were adequate. Nine participants in the PTSD group were 
involved in litigation, and one was excluded from the study, as the subject did not meet the symptoms 
criteria during the evaluation process. None of the participants in the MTBI group were involved in 
litigation at the time of the evaluation. 
2.3. Exclusion Criteria 
Exclusion criteria for the present study were the following: (1) unstable medical conditions, past 
history of traumatic brain injury before the more recent one or other diseases with the potential to affect 
brain functioning in pre- or post-trauma; (2) existing substance abuse problem; (3) learning disorder or 
attention deficit in school; (4) history of physical violence during infancy; (5) an incapacitating physical 
disorder that is not adequately controlled; (6) a psychotic episode (past or present); and (7) a bipolar 
disorder or an organic mental disorder. 
Of the 135 participants recruited or referred to the study, we excluded thirty five PTSD participants, 
twenty two MTBI participants and two controls. The percentage of excluded participants in each group 
was as follows: 58.3% in the PTSD group (35 excluded/60 recruited), 52.4% in the MTBI group (22/42), 
7.4% in the control group (2/27) and 0 in the MTBI/PTSD group (0/6). The primary reasons for exclusion, 
in descending order, were the following: dropped out or were no longer interested (11 PTSD; 5 MTBI); 
suspected or confirmed prior brain injury (9 PTSD; 1 control); uncontrolled medical condition (6 PTSD; 
3 MTBI; 1 control); age over 60 years (3 PTSD; 4 MTBI); history of drug or alcohol abuse (2 PTSD;  
4 MTBI); insufficient French language skills (2 PTSD; 2 MTBI); suspected visual, sensory or motor 
problems (2 MTBI); developmental attention problems (1 PTSD; 1 MTBI); suspected bipolar disorder 
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(1 MTBI); and suspected malingering (1 PTSD). The fact that 50% of the recruited participants in the 
PTSD and MTBI groups were excluded confirms the importance of controlling for the high comorbidity 
that can occur in these populations to avoid attributing participants’ complaints to conditions other than 
PTSD and MTBI. 
2.4. Procedure 
Subjects were informed that participation in the study was voluntary. All participants provided written 
consent prior to the study. As a prerequisite for entering the study, participants underwent a complete 
psychological screening, including a formal evaluation to establish the presence of PTSD as a primary 
condition and to evaluate possible secondary conditions, such as anxiety. Self-report questionnaires 
regarding cognitive and behavioral changes observed post-trauma were completed in the context of a 
neuropsychological evaluation (results not presented here). 
The study was conducted at Louis-H Lafontaine Hospital in Montreal (Quebec, Canada) and at the 
Lucie Bruneau Rehabilitation Centre. The study was approved in January 2006 (#CER CRIR-138-0405), 
by the ethics committees at Louis-H Lafontaine Hospital in Montreal (Quebec) and the Centre de 
Recherche Interdisciplinaire en Réadaptation (CRIR) (Centre for Interdisciplinary Research in 
Rehabilitation), with which the Centre de Réadaptation Lucie-Bruneau was affiliated. The same 
evaluator met with each participant at one or the other centre, according to the origin of the referral. 
Questionnaires were completed at home between evaluation sessions. 
2.5. Assessment 
2.5.1. Psychological Condition 
Participants were included in the PTSD group only if PTSD was the primary diagnosis and if all other 
psychological conditions (e.g., depression) were secondary to PTSD. The diagnoses were established 
using the Structured Clinical Interview for DSM-IV for Axis I disorders (SCID; Firsta nd Spitzer [11]). 
The Clinician Administered PTSD Scale for DSM-IV-Revised (CAPS; Blake, Weathers [12]) was 
administered to establish the frequency and severity of PTSD symptoms in the PTSD and MTBI groups. 
A trained psychologist, who was blind to the participants’ psychological conditions, administered the 
structured interviews. The Beck Depression Inventory (Beck-II; Beck, Steer [13]) was used to evaluate 
symptoms of depression, while the intensity of anxiety symptoms was measured with the State-Trait 
Anxiety Inventory (STAI; Spielberger, Gorsuch [14]). Although participants taking medication 
(antidepressants, anxiolytics and pain killers) were not excluded, the medication regimens had to remain 
stable during the evaluation process. We screened for eligible participants until achieving the intended 
sample size, and we excluded those presenting the exclusion criteria described before. 
2.5.2. Assessment of Cognitive and Behavioral Complaints 
The Cognitive Failure Questionnaire (CFQ; Broadbent, Cooper [15]) and the Frontal Systems 
Behavior Scale (FrSBe; Grace and Malloy [16]) were used to evaluate cognitive and behavioral 
problems. The CFQ is a 25-item self-report measure of cognitive failure in perception (e.g., failure to 
find an item at the supermarket, although it is there), memory (e.g., failure to remember names) and 
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motor function (e.g., inadvertently bumping into people) in everyday functioning. The five-point Likert 
scale measures frequency, from 0 (never) to 4 (very often), for each cognitive failure. For the purpose 
of the present study, we identified two time periods (pre- and post-trauma/accident) for the PTSD group. 
The Frontal Systems Behavior Scale [16] measures behavior associated with frontal lobe dysfunction. 
It is comprised of 46 items divided in three subscales: apathy, disinhibition and executive yield three 
subscales scores and a total score. In addition to the self-report form, the scale includes a rating form to 
be completed by a relative as a way to provide independent assessments of the behavior problems 
reported by the participant. Participants and relatives used a five-point Likert scale to estimate the 
frequency of each behavior from 1 (never) to 5 (almost always) pre-/post-event. The pre- and  
post-conditions are defined by the subject’s perception “before the traumatic event” (pre-) and “actual” 
(post-), i.e., since the traumatic event. For the control group, the subjects only reported their perception 
for the actual condition. Relatives completed the questionnaire and returned it by mail, anonymously. 
All of the questionnaires used in the present study have good psychometric properties. 
2.5.3. Statistical Analyses 
The first step in the statistical procedure was to compare the results of the three clinical groups with 
those of the control group for age, gender, education and elapsed time since the trauma, in order to 
determine whether or not the groups were equivalent (see Table 1). Second, the clinical and control 
groups were compared on clinical variables, including depression (BDI-II) and trait and state anxiety 
(STAI). Third, the results were obtained by the clinical and control groups on the measures of cognitive 
(Figure 1) and behavioral problems (Table 2 and Figure 2), to determine whether or not the clinical 
groups’ symptoms were greater than the symptoms reported in the general population. Finally, multiple 
regression analyses were conducted to establish the relative independent contributions of depressive, 
anxious and post-traumatic conditions to the intensity of reported cognitive problems, behavioral 
problems and fatigue. 
Table 1. Summary of clinical and control variables. 
 PTSD  MTBI  MTBI/PTSD Controls F (df) Part. η2
Variables (n = 25) (n = 19) (n = 6) (n = 25)   
Control M (SD) M (SD)  M (SD) M (SD)   
Age 38.5 (12.4) 40.3 (14.7) 33.3 (15.9) 38.9 (12.6)   
Female a Education 
19/25 (76.0%) 
14.8 (3.1) 
9/19 (47.4%) 
13.4 (3.9) 
2/6 (33.3%) 
12.8 (3.1) 
19/25 (76.0%) 
15.4 (2.6) 
  
Elapsed time  
(in months) 
48.5 (41.8) 
(range 2–146) 
30.7 (31.6) 
(3–98) 
9.0 (2.9)  
(4–11) 
N/A F (2, 47) 3.44 * 0.13 
Clinical M (SD) M (SD) M (SD) M (SD)   
BDI-II Total score 29.8 b (13.0) 11.6 d (11.4) 23.8 b (10.6) 4.8 b (5.0) F (3, 65) 25.81 ** 0.54 
STAI State 54.0 c (11.0) 37.6 c (12.9) 43.3 (7.8) 29.3 (6.3) F (3, 67) 25.65 ** 0.53 
STAI Trait 59.5 c (10.2) 41.1 c (14.3) 55.8 (8.6) 32.6 (10.4) F (3, 67) 25.18 ** 0.53 
Notes: BDI-II = Beck Depression inventory version II; STAI State = State-Trait Anxiety Inventory, state 
version; STAI Trait = State-Trait Anxiety Inventory, trait version. a The female/male ratio is not equivalent 
across groups (Fisher’s exact test, p = 0.047). Due to missing data, n was 1 b, 2 c or 3 d lower. * p < 0.05.  
** p < 0.01.  
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Figure 1. Example of most frequent responses to Cognitive Failure Questionnaire (CFQ) 
(“often” and “very often”). 
Table 2. Participants’ self and relatives’ Frontal Systems Behavior Scale (FrSbe) scores. 
Means and Standard Deviations for Behavioural Dimensions Post-Event 
Group a PTSD MTBI MTBI/PTSD Control   
Dimension M (SD) M (SD) M (SD) M (SD) F (df) b Part. η2
Apathy       
Self 43.3 (9.7) 33.8 (10.0) 43.3 (11.0) 23.6 (6.4) 21.96 ** 0.49 
Relative 36.7 (10.6) 30.1 (12.7) 42.2 (5.4) 23.9 (6.7) 7.59 ** 0.30 
Disinhibition       
Self 36.5 (8.5) 32.1 (9.6) 37.8 (7.1) 25.8 (5.1) 9.12 ** 0.28 
Relative 31.8 (7.3) 30.5 (11.6) 38.8 (9.6) 25.7 (6.5) 3.67 * 0.17 
Executive       
Self 48.0 (9.6) 42.9 (13.2) 50.1 (13.7) 28.8 (6.6) 17.23 * 0.43 
Relative 46.2 (11.1) 41.3 (17.2) 53.2 (10.2) 31.9 (11.5) 5.66 ** 0.25 
Total       
Self 127.8 (23.7) 108.8 (28.1) 131.2 (29.8) 76.6 (18.9) 21.26 ** 0.48 
Relative 114.7 (26.1) 102.0 (39.5) 134.2 (18.2) 79.3 (18.0) 7.97 ** 0.31 
Note: Only post-trauma scores are reported. There were no significant group differences for pre-event scores. 
a Due to missing data, n differs for self and relative scores, respectively, in the PTSD group (n = 23 and 20), 
the MTBI group (n = 19 and 13), the MTBI/PTSD group (n = 6 and 5) and the control group (n = 25 and 18). 
b For self-scores, df = (3, 69), and for relative scores, df = (3, 52). * p < 0.05. ** p < 0.01. 
Descriptive and parametric analyses were conducted using SPSS version 15. Fisher’s exact test was 
used to compare the male-to-female ratios between groups. One-way ANOVAs were conducted on four 
levels of dependent variables (groups). Post hoc analyses compared two groups at the same time by 
means of a t-test. Statistical significance was set at p < 0.05. When the distribution of pooled data scores 
did not respect the assumptions of normality, score transformations (square roots or logarithms) were 
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performed. Questionnaires with over 10% missing data were excluded from analyses. Missing data were 
replaced using the mean substitution method. 
 
Figure 2. The most common changes reported by clinical groups on FrSBe dimensions. 
3. Results 
3.1. Control and Clinical Variables 
Significant differences in means on control and clinical variables are reported in Table 1. 
There were no statistically significant group differences in age or education level, but significant 
differences between groups (Fisher’s exact test, p < 0.05) were observed in the ratio of male to female 
participants. The MTBI/PTSD group reported significantly less elapsed time since the trauma than did 
the PTSD group. Regarding clinical variables, a significant main effect of group was found on the BDI 
and STAI inventories. Post hoc analysis revealed that the PTSD and MTBI/PTSD groups were 
significantly more depressed than the control (t(1, 48) = 8.97, p < 0.05 and t(1, 29) = 6.60, p < 0.05, 
respectively) and MTBI group (t(1, 42) = 4.85, p < 0.05 and t(1, 23) = 2.32, p < 0.05, respectively). For 
anxiety dimensions, the PTSD group’s scores were significantly different from control (PTSD group for 
anxiety state: t(1, 48) = 9.74, p < 0.05; and for anxiety trait: t(1, 48) = 9.23, p < 0.05, respectively; 
MTBI/PTSD group for anxiety state: t(1, 29) = 4.68, p < 0.05; and for anxiety trait: t(1, 29) = 5.05,  
p < 0.05, respectively). Finally, the MTBI group did not differ significantly from controls on depression 
and anxiety scores (all post hoc comparisons >0.05). 
3.2. Primary and Secondary Diagnoses 
Table 3 qualitatively resumes the distribution of the severity of PTSD conditions. This severity of the 
PTSD condition was established by clinicians based on the SCID interview. The data only concern the 
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PTSD and MTBI/PTSD groups, since MTBI and control, by definition, do not have PTSD according to 
the inclusion criteria. The proportion of participants suffering from a PTSD diagnosis specified as 
moderate and severe (as assessed by the SCID-I) was greater in the PTSD group (64%) than in the 
MTBI/PTSD group (17%). Furthermore, 32% of participants in the PTSD group reported severe PTSD 
diagnosis, while none did in the MTBI/PTSD group. In the latter group, the majority of participants 
presented mild and moderate PTSD diagnoses (33%). Furthermore, participants presented sub-clinical 
symptoms (33%) or partial PTSD (17%) in the MTBI group. In contrast, only 4% of participants in the 
PTSD group presented sub-clinical symptoms at the time of the evaluation. Based on Mylle and  
Maes’ [17] recommendations, the “sub-clinical” PTSD category includes the cases that did not reach the 
number of symptoms required for Criterion C (avoidance) or D (neurovegetative hyperactivity), 
although at least one symptom of every criterion was present. The second category indicated by the term 
“partial” PTSD refers to the cases where one or another of the criteria is missing (intrusion and  
hyper-awakening) in spite of the significant presence of the F criterion. 
Results on the SCID revealed that the PTSD group presented more secondary diagnoses than did the 
MTBI group. Secondary diagnoses reported by participants in the PTSD group included mood and 
anxiety disorders. 
Table 3. Percentage of the PTSD group according to the severity of symptoms. 
Severity of Symptoms PTSD (%) MTBI/PTSD (%) 
Severe 32 0 
Moderate/severe 64 33 
Light/moderate 0 17 
Partial/sub-clinical 4 50 
3.3. Cognitive and Behavioral Symptoms 
3.3.1. Cognitive Failure Questionnaire 
Higher scores on the CFQ indicate more reported cognitive failures. Significant main effects of group 
were observed pre-/post-traumatic event, F(3, 69) = 3.48, p = 0.02 and F(3, 69) = 20.03, p = 0.00, 
respectively. Post hoc comparisons confirmed a statistically significant difference post-event between 
the control (M = 28.60, SD = 11.93) and clinical groups (PTSD: M = 63.20, SD = 13.33; MTBI:  
M = 48.95, SD = 23.37; MTBI/PTSD: M = 58.50, SD = 9.83). Comparisons between clinical groups 
revealed that participants in the PTSD group reported significantly greater distractibility (p < 0.05) than 
did the MTBI participants. Figure 1 shows the percentage of individuals in each group who endorsed the 
most common complaints (“often” and “very often” combined) since the event. Across the nine most 
frequently reported complaints, the median percentages were 57%, 37%, 50% and 8% for the PTSD 
group, MTBI group, MTBI/PTSD group and control group, respectively. 
As illustrated in Figure 1, more than 70% of participants in the PTSD group reported being easily 
distracted and not attentive to others, while 83% of participants in the MTBI/PTSD group reported 
forgetting appointments. Needing to reread material due to difficulty concentrating was reported by  
95% of participants in the PTSD and MTBI/PTSD group, but only 63% of the MTBI group. 
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3.3.2. Self-Report of Frontal Behavior (FrSBe) 
Table 2 describes the mean self-report and relative report scores on the FrSBe scale for the participant’s 
behavior since the event. Higher scores indicate greater perceived behavior changes. The total score is 
the sum of three dimensions of frontal behavior: apathy, disinhibition and executive dysfunction. 
ANOVA tests were conducted between the pre- post-event scores of all groups (except for the control 
group, since this group has, of course, no post-event condition). The main effects are presented first, 
followed by the participants’ most frequently reported qualitative changes since the event. 
Significant main effects were found between all groups for the total and subscale scores. Post hoc 
comparisons confirmed that the clinical groups reported significantly more complaints than controls 
(pre-event), except for the MTBI group, which did not differ from the control group on disinhibition 
dimension (p = 0.07). PTSD participants self-reported significantly more apathetic behavior (t (1,42) = 3.18, 
p < 0.05) since the event (mean self-score = 43.3) than the MTBI group (mean self-score = 33.8).  
No other comparisons between clinical groups reached statistical significance. 
3.3.3. Perceptions of Relatives 
A significant main effect of group was found for every dimension, as well as for total score, on the 
FrSBe family version (see Table 2). Post hoc comparisons confirmed that the mean scores for the PTSD 
and MTBI/PTSD groups’ relative reports for apathy and executive dysfunction were significantly 
different from the means of the control group’s relative reports on these dimensions. Only relatives of 
participants in the MTBI/PTSD reported significantly more complaints on the disinhibition dimension 
post-event. Despite complaints reported by the MTBI group, their relatives did not report significant 
changes on any of the FrSBe dimensions since the event. The MTBI/PTSD and PTSD groups reported 
more problems since the event on all three FrSBe subscales, but only the former group’s complaints 
since the trauma were externally validated by relatives. 
3.3.4. Most Frequently Reported Behavioral Changes 
Figure 2 shows the most frequent changes reported by clinical groups and their relatives for each 
behavioral dimension post-trauma. The scores represent the difference in pre-/post-event scores for the 
most frequently reported items in each group. Negative scores indicate change (in the sense of 
deterioration) in behavior; a score of zero indicates no perceived change post-event. 
As shown in Figure 2, the participants in the PTSD group reported the most perceived change  
post-event. The biggest discrepancies between participants and their relatives in the perceived most 
frequent changes were in the PTSD group. 
4. Discussion 
The present exploratory study was designed to respond to three research questions: (1) Given the 
overlap in clinical symptoms between PTSD and MTBI, are the cognitive and behavioral problems 
reported by individuals in the two groups similar in nature and intensity? (2) Does the presence of 
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comorbid MTBI and PTSD increase the intensity of symptoms? (3) Are the symptoms reported by the 
three clinical groups (MTBI, PTSD and MTBI/PTSD) independently validated by close relatives? 
4.1. Differences in Intensity and Specificity of Cognitive and Behavioral Complaints in PTSD and 
MTBI Groups (Question 1) 
In the present study, the three clinical groups reported greater cognitive problems since the traumatic 
event than did the control group. The PTSD group reported significantly more daily distractibility and 
forgetfulness than did the MTBI group, while the MTBI group reported significantly more distractibility 
than did the control group. The qualitative analysis of individual symptom profiles allowed us to identify 
the symptoms most frequently reported by the participants in each group or by their relatives. 
The results on behavioral change revealed that the three clinical groups reported more apathetic, 
disinhibited and disorganized behavior than did the control group. Only the MTBI group does not differ 
from the control on the self-reported measure of disinhibition. The PTSD group reported significantly 
greater apathy post-event than did the MTBI group. Irritability figured among the most common qualitative 
changes reported by the PTSD group, but not by the MTBI group. The predominant manifestation of 
apathy reported by participants in the PTSD group was loss of interest in initiating and participating in 
activities; this complaint was not common among participants in the MTBI group. As for executive 
functioning, a significant increase in distractibility was reported by participants of the PTSD group, but 
not as much by participants in the double diagnosis or MTBI groups. 
In sum, the findings suggest that the PTSD group reported more complaints than the MTBI group and 
that some complaints could differ qualitatively between groups. However, these qualitative observations 
must be replicated in more subjects to ensure the significance of the present qualitative observations. 
However, the specific contribution of post-traumatic stress to this result is difficult to establish due to 
the strong comorbidity of anxious and depressive symptoms associated with trauma symptoms in 
individuals with PTSD (with or without MTBI). Furthermore, the fact that the severity of PTSD 
symptoms was mild to sub-clinical in the double diagnosis group suggests a significant contribution of 
general anxiety and depression symptoms in the expression of complaints in the PTSD and  
MTBI/PTSD groups. 
4.2. Cumulative Effect of MTBI and PTSD (Question 2) 
Due to the limited number of participants in the MTBI/PTSD group, data must be interpreted with 
caution. Nonetheless, some qualitative observations made in the present study could seem consistent 
with the suggestion that the comorbidity MTBI/PTSD could produce a cumulative detrimental effect on 
the expression of cognitive and behavioral symptoms. Again, more quantitative data in the future are 
necessary to confirm these hypotheses. Further, it is important to note that the specific contribution of 
PTSD symptoms to these complaints is even more difficult to establish in the MTBI/PTSD group, 
because the severity of PTSD symptoms was much less intense in this group than in the PTSD group, 
whereas the intensity of anxious and depressive symptoms between the two groups was comparable. 
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4.3. External Validation of Symptoms by Relatives (Question 3) 
One of the original elements in the present study was that the complaints reported by the participants 
with PTSD (with or without MTBI) were subjected to external validation by relatives. The fact that only 
the MTBI/PTSD group’s complaints on the FrSBe dimensions were validated by relatives supports the 
hypothesis of a “cumulative effect” of MTBI and PTSD on “more visible” behavioral changes. In fact, 
despite PTSD participants’ reports of disinhibition, their relatives did not perceive a major change on 
this variable. However, relatives were more likely to identify apathy and disorganization in the PTSD 
group than in the control group. 
Altogether, the results of the present study support the hypothesis that the presence of post-traumatic 
symptoms and of significant comorbidity can modulate reports of cognitive and behavioral symptoms 
in individuals with PTSD. The results further suggest that cognitive and behavioral problems could be 
exacerbated in individuals with more severe traumatic, depressive and anxious symptoms. However, 
these interpretations do not entirely explain the results obtained, particularly regarding the double 
diagnosis group. 
4.4. Alternative Explanations 
Anxious and depressive comorbidity in PTSD: Only the MTBI/PTSD group was validated by 
relatives on their reported difficulties in emotional self-control, apathy and executive dysfunction. This 
group also reported more forgetfulness than did the other clinical groups. However, it is difficult to 
attribute this result to the post-traumatic stress condition, since there is a comorbidity in PTSD groups 
(PTSD and MTBI/PTSD). Further, if post-traumatic symptoms have a major impact on participants’ 
reported complaints, we would expect the PTSD group to report at least as many problems as the double 
diagnosis group, particularly concerning irritability and forgetfulness, since trauma symptoms are more 
severe in the PTSD group than in the MTBI/PTSD group. These observations suggest that the greater 
reported complaints in the PTSD and MTBI/PTSD groups, as compared to the MTBI group, can be 
attributed at least in part to psychological comorbidity. 
Litigation: One could argue that the greater number of complaints in the PTSD group may be 
attributable to involvement in a litigation process at the time of evaluation. However, it was not expected 
that the effects disappeared once the participants in the process of litigation were removed from the 
analyses, but rather that the results remained the same. This outcome suggests that the significant 
subjective adjournment of complaints by the groups is not artificially inflated by the inclusion of subjects 
that are in the process of litigation to make their difficulties recognized. 
Elapsed time since the trauma: A third possible explanation for the results concerns the observed 
significant difference between elapsed time since the trauma in the PTSD group and MTBI/PTSD 
groups, respectively, at the time of evaluation. The latter group reported less elapsed time (average of 
nine months) than did the PTSD group (average of 48 months). This result may suggest the presence of 
a persistent adverse impact of MTBI injury in the double diagnosis group; these participants may have 
only recently begun facing the difficult post-trauma sequelae or may have less well-developed coping skills. 
Interaction between emotional distress and MTBI sequelae: One plausible explanation for the greater 
reported disinhibition and forgetfulness in the MTBI/PTSD group is an interaction between significant 
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emotional distress and a subtle decrease in self-regulation capacities, due to the damage to the  
fronto-temporal part of the brain during the traumatic event [1,18–21]. Over the past few years, 
neuroradiology data collected with functional imaging techniques have provided evidence of subtle 
neurological sequelae in the frontal and/or temporal lobes of the brain in certain subgroups of individuals 
with MTBI [20,22–24]. The subtle neurological damages may explain the presence of persistent  
post-concussive sequelae beyond the expected psychological reaction to PTSD in individuals with 
MTBI/PTSD [25,26]. 
4.5. Clinical and Research Considerations 
The principal contribution of the present study was an increased understanding of the nature and 
severity of cognitive and behavioral complaints reported by individuals with PTSD and MTBI, taking 
comorbidity and antecedent factors into consideration. The results are partially compatible with findings 
from Hoge, McGurk [10] and Chamelian and Feinstein [8], which reported that post-traumatic and 
depressive symptoms caused memory and attention problems in individuals with PTSD post-trauma. 
From a clinical perspective, the current study presents some cues about the degree of congruence between 
participants’ and relatives’ perceptions of symptoms, as well as the extent of discrepancy in perception. 
Such observations could improve the comprehension of PTSD symptoms among patients and relatives 
alike, as well as facilitate the development of personalized interventions. 
4.6. Strengths and Limitations of the Study 
A major strength of the study was that participants’ medical antecedents were controlled. The inclusion 
of a control group, paired by age, education and gender with the clinical group, allowed us to document 
and to compare the frequency of cognitive and behavioral complaints in a normative sample. Instead of 
using only general questions about cognitive symptoms, the present study used three detailed self-report 
questionnaires to better capture the nature and intensity of cognitive and behavioral symptoms pre- and 
post-traumatic event. Diagnoses of MTBI and PTSD were established from medical history and through 
a formal interview based on DSM-IV-TR criteria [27]. The addition of inclusion and exclusion criteria 
allowed us to ensure that the reported symptoms were not attributable to pre-existing attention and 
learning deficits [28], alcohol abuse [29], brain injury [4] or medical conditions that could diminish 
cognitive capacities. The presence of psychological conditions commonly comorbid with PTSD and 
MTBI (e.g., anxiety, depressive symptoms and fatigue) were controlled. 
One major limitation of the study is the size of the double diagnosis group. This small sample size 
limited the possibility of testing Vanderploeg et al.’s hypothesis [9] regarding a “cumulative” effect of 
concomitant MTBI and PTSD diagnoses on cognitive and behavioral complaints. A second significant 
limitation of the study was that the questionnaires used to measure cognitive and behavioral complaints 
have not been validated for PTSD and/or MTBI populations. This limitation restricts interpretation of 
the results and highlights the need to develop validated instruments specific to each clinical population. 
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4.7. Future Considerations and Clinical Implications 
The results of the present study demonstrate the need for the further exploration of factors influencing 
the cognitive and behavioral changes perceived and reported by individuals with PTSD and MTBI  
and their relatives. The development of specific and sensitive instruments for each of these populations 
will allow finer evaluation of the overlap in cognitive and behavioral problems across neurological  
and psychiatric conditions. The cognitive and behavioral changes that develop following a traumatizing 
event often impact both the patients’ and family members’ lives; an improved comprehension of the 
changes that appear post-trauma would promote the development of personalized clinical interventions 
for individuals and for family members of individuals with PTSD and MTBI. 
5. Conclusions 
The present study was the first that was designed to directly compare subjective cognitive and behavioral 
complaints in PTSD (with and without MTBI) and MTBI (without PTSD) populations. The results 
confirmed that complaints vary not only by diagnosis, but also according to psychological condition. 
The fact that complaints reported in the PTSD group were partially noted by independent observers 
further validates the participants’ complaints. Finally, the results suggest that the presence of both MTBI 
and PTSD exacerbates psychological comorbidity and other symptoms, such as memory problems,  
at least during the first year after the trauma. Subtle fronto-temporal sequelae of MTBI, which may 
compromise self-regulation capacities and lead to deficits in cognitive and emotional regulation [18], 
have been proposed as alternative hypotheses to explain cognitive and adaptation problems in real life. 
In clinical settings where formal neuropsychological evaluation is not available and the use of self-report 
questionnaires for evaluating cognitive and behavioral symptoms may be recommended. The results of 
questionnaire measures could guide clinical interventions, such as psychoeducation and cognitive 
restructuring, to help PTSD victims and their family members better understand and cope with the 
cognitive and behavioral changes. 
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